Advaxis, Inc. announced the appointment of Bradley J. Monk, MD, FACOG, FACS as Lead Cervical Cancer Advisor to the Company. Dr. Monk will be leading the development of Advaxis Lm Technology platform and assisting with the Company's multiple clinical programs, including those in HPV-associated cancers (cervical, anal, and head and neck), HER2 expressing tumors and prostate cancer. Dr. Monk brings to Advaxis more than 25 years of experience in medical oncology and clinical research.

Notably, he serves as the co-primary investigator of GOG 0265. Dr. Monk is currently director of the Division of Gynecologic Oncology at St. Joseph's Hospital and Medical Center.